Drawing for OSNA

USPTO serial 87927734

OSNA

Reviewed by CopyMark Law Group

Reg. 7204197Status 700Registered
Filing date
Status date
Registration date
Oct 31, 2023
Examiner
RADEMACHER, APRIL LUEDERS
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with OSNA?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Virginia Wolk Marino

Virginia Wolk Marino CROWELL & MORINGP.O. BOX 10395CHICAGO, IL 60610UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
005Diagnostic reagents and diagnostic preparations for medical or veterinary purposes; chemical reagents and chemical preparations for medical or veterinary purposes; chemical reagents and chemical preparations for medical or pharmaceutical purposes, namely, reagents for detecting metastasis of cancer; testing reagents and preparations for medical or veterinary purposes; pharmaceutical preparations for in vitro diagnosis; reagents for medical use, namely, reagents for genetic test; reagents for medical use, namely, reagents for amplification and detection of genes; reagents for medical use, namely, lymph node solubilizing reagents; reagents for medical use, namely, reagents for protein test; reagents for medical use, namely, reagents for cancer recurrence prediction test; reagents for medical use, namely, reagents for anticancer drug sensitivity prediction test; diluents for medical or veterinary purposes; diluents for medical or clinical diagnostic use; diluents for genetic test for medical or clinical diagnostic use; reference control materials for medical use; quality control standard solutions and quality control reagents for testing and calibrating medical apparatus and reagentsACTIVE—
009Gene amplification or detection device for scientific or research use, namely, for detecting metastasis of cancer; laboratory apparatus and instruments, namely, for genetic testing for scientific and research purposes; measuring or testing machines and instruments for analyzing blood, body fluid, tissue or other biological samples not for medical purposesACTIVE—
010Diagnostic apparatus and instruments for medical purposes, namely, for testing DNA or RNA; diagnostic or measuring apparatus and instruments for medical purposes in the nature of genetic testing apparatus and instruments, namely, gene amplification detector, cancer metastasis analyzer, cell cycle analyzer, cancer recurrence prediction testing apparatus and instruments, anticancer drug sensitivity prediction testing apparatus and instruments, sample transfer apparatus, sample container transfer apparatus, and sample rack transfer apparatus; measuring apparatus and instruments for medical purposes for analyzing genes; pipettes for medical purposes; containers for samples for in vitro diagnosis; sampling bottles for medical purposesACTIVE—
042Medical or scientific research on cancer diagnosis; medical research; providing information relating to medical research; testing, examination or research of reagents and other medicines; testing, examination or research of medical apparatus and instruments and other machines; technological advice relating to medical apparatus and instruments, laboratory apparatus and instruments, measuring or testing machines and instruments, testing apparatus and instruments, computers and other machines; rental of gene amplification or detection device for scientific or research use; rental of laboratory apparatus and instruments; rental of measuring or testing machines and instruments for medical or scientific research; all of the foregoing for use with medical and scientific research in the field of cancer diagnosisACTIVE—
044Clinical genetic testing for detecting metastasis of cancer for diagnostic or treatment purposes; clinical testing of genes in lymph node for medical purposes; providing information relating clinical testing, namely, genetic testing; medical analysis and evaluation of clinical laboratory tests results for diagnosis of cancer metastasis or other diseases; providing medical information in the field of genetic testing; rental of medical apparatus and instrumentsACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Oct 31, 2023NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
Oct 31, 2023R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Aug 3, 2022TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Aug 3, 2022EWAFTEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS—
Aug 3, 2022ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Aug 3, 2022REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Jun 3, 2022ERRRON HOLD - ELECTRONIC RECORD REVIEW REQUIRED—
Jun 1, 2022DP1B1(B) BASIS DELETED; PROCEED TO REGISTRATION—
May 20, 2022IUCNNOTICE OF ALLOWANCE CANCELLED—
May 20, 2022D1BRTEAS DELETE 1(B) BASIS RECEIVED—
Nov 16, 2021EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Nov 15, 2021EX5GSOU EXTENSION 5 GRANTED—
Nov 15, 2021AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Nov 8, 2021EXT5SOU EXTENSION 5 FILED—
Nov 8, 2021EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
May 8, 2021EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
May 6, 2021EX4GSOU EXTENSION 4 GRANTED—
May 6, 2021EXT4SOU EXTENSION 4 FILED—
May 6, 2021EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Nov 6, 2020EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Nov 4, 2020EX3GSOU EXTENSION 3 GRANTED—
Nov 4, 2020EXT3SOU EXTENSION 3 FILED—
Nov 4, 2020EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Feb 11, 2020EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Feb 7, 2020EX2GSOU EXTENSION 2 GRANTED—
Feb 7, 2020EXT2SOU EXTENSION 2 FILED—
Feb 7, 2020EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Oct 8, 2019CHPBPOST PUBLICATION AMENDMENT - ENTERED—
Sep 25, 2019EWAFTEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS—
Jun 14, 2019EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Jun 12, 2019EX1GSOU EXTENSION 1 GRANTED—
Jun 12, 2019EXT1SOU EXTENSION 1 FILED—
Jun 12, 2019EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
May 28, 2019NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Apr 2, 2019NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Apr 2, 2019PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Mar 13, 2019NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Feb 22, 2019ALIEASSIGNED TO LIE—
Feb 6, 2019CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Nov 28, 2018TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Nov 27, 2018CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Nov 27, 2018TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jun 23, 2018GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jun 23, 2018GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jun 23, 2018CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jun 7, 2018DOCKASSIGNED TO EXAMINER—
May 26, 2018NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
May 22, 2018NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance